In contrast, ASPSCR1-TFE3 expression in the Sglt2-Cre lineage led to tRCC with complete penetrance and short latency. The gene discussed is SLC5A2; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.